2011
DOI: 10.1002/jps.22693
|View full text |Cite
|
Sign up to set email alerts
|

Poor oral bioavailability of a promising anticancer agent andrographolide is due to extensive metabolism and efflux by P‐glycoprotein

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

4
86
0
3

Year Published

2013
2013
2021
2021

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 116 publications
(93 citation statements)
references
References 25 publications
4
86
0
3
Order By: Relevance
“…Andrographolide and diverse other extractable secondary metabolites of A. paniculata possess bactericidal, fungicidal and antiviral activities (Sareer et al 2012), and oral bioavailability of andrographolide (as judged by its observed blood levels after oral intake) is low (Panossian et al 2000;Ye et al 2011). Andrographolide modulates physiological functions of diverse drug metabolising enzymes in liver and other peripheral organs as well (Pekthong et al 2008), and binds covalently with cellular metabolites and enzymes (Xia et al 2004).…”
Section: Discussionmentioning
confidence: 99%
“…Andrographolide and diverse other extractable secondary metabolites of A. paniculata possess bactericidal, fungicidal and antiviral activities (Sareer et al 2012), and oral bioavailability of andrographolide (as judged by its observed blood levels after oral intake) is low (Panossian et al 2000;Ye et al 2011). Andrographolide modulates physiological functions of diverse drug metabolising enzymes in liver and other peripheral organs as well (Pekthong et al 2008), and binds covalently with cellular metabolites and enzymes (Xia et al 2004).…”
Section: Discussionmentioning
confidence: 99%
“…17,18 However, the oral bioavailability of AG is low because of its low aqueous solubility (0.07 mg/mL in water) and low oral absorption due to rapid and extensive metabolism and efflux by P-glycoprotein (P-gp) in the intestine. 19,20 Thus, to overcome the problem of low oral bioavailability, improvements to the solubility of AG and prevention of its efflux by P-gp are urgently required.…”
Section: Introductionmentioning
confidence: 99%
“…5,6 The potential use of ADG has attracted wide attention in recent years. Unfortunately, the clinical use of ADG remains challenging due to its extremely poor solubility (1.32×10 -7 M in water at 25°C) and efflux by P-glycoprotein (P-gp), [7][8][9] which results in low bioavailability after oral administration.…”
Section: Introductionmentioning
confidence: 99%